IRCT201110083010N3已完成2 期
The study of the efficacy of rivastigmin in cognitive status of schizophrenic patients
Kermanshah University of Medical Sciences and Health Services0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 65 years（—）
- 性别
- All
入选标准
- •Inclusive criteria: 1) the diagnosis of schizophrenia made by the psychiatrist based on DSM.IV.TR; 1) the presence of some cognitive deficits; 3) being volunteer to participate in the study; 4) being under treatment with atypical antipsychotic medications. Exclusion criteria: 1) disagreement to participate in the study; 2) treatment with typical antipsychotic agents; 3) absence of any of inclusive criteria; 4) concordance of substance dependence disorders; 5) co-morbidity with organic mental disorders.
排除标准
- 未提供
研究者
相似试验
招募中
3 期
Evaluation of the effect of rivastigmine on male patients with chronic schizophreniaIRCT20120314009297N8Mazandaran University of Medical Sciences60
招募中
3 期
Effectiveness of Rivastigmine and Donepezil on cognitive disordersIRCT20210819052232N1Esfahan University of Medical Sciences165
已完成
2 期
Efficacy of rivastigmin in the treatment of major depressive disorderIRCT2017020132236N4Vice chancellor for research, Mazandaran University of Medical Sciences20
招募中
3 期
Rivastigmine effect on mild cognitive impairment patients decision makingMild Cognitive Impairment (MCI).Mild cognitive impairment, so statedG31.84IRCT20201104049257N1Tehran University of Medical Sciences40
已完成
不适用
Investigation on efficacy and safety of rivastigmin patch in patients switched from donepezil with mild to moderate Alzheimer's diseaseJPRN-UMIN000010842Kagawa University School of Medicine100